132 related articles for article (PubMed ID: 10914427)
1. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder.
Ordóñez NG; Mackay B
Ultrastruct Pathol; 2000; 24(3):157-67. PubMed ID: 10914427
[TBL] [Abstract][Full Text] [Related]
2. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
3. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
Ordóñez NG
Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
[TBL] [Abstract][Full Text] [Related]
5. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
6. Brenner tumor of the ovary: a correlative histologic, histochemical, immunohistochemical, and ultrastructural investigation.
Santini D; Gelli MC; Mazzoleni G; Ricci M; Severi B; Pasquinelli G; Pelusi G; Martinelli G
Hum Pathol; 1989 Aug; 20(8):787-95. PubMed ID: 2744751
[TBL] [Abstract][Full Text] [Related]
7. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
[TBL] [Abstract][Full Text] [Related]
9. Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma.
Takeuchi T; Ohishi Y; Imamura H; Aman M; Shida K; Kobayashi H; Kato K; Oda Y
Am J Surg Pathol; 2013 Jul; 37(7):1091-9. PubMed ID: 23681072
[TBL] [Abstract][Full Text] [Related]
10. Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
Pfarr N; Darb-Esfahani S; Leichsenring J; Taube E; Boxberg M; Braicu I; Jesinghaus M; Penzel R; Endris V; Noske A; Weichert W; Schirmacher P; Denkert C; Stenzinger A
Genes Chromosomes Cancer; 2017 Oct; 56(10):758-766. PubMed ID: 28639280
[TBL] [Abstract][Full Text] [Related]
11. [Benign and malignant Brenner tumor of the ovary: a clinicopathological and immunohistochemical study].
Peng ZN
Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):333-5. PubMed ID: 1284387
[TBL] [Abstract][Full Text] [Related]
12. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features observation of ovarian transitional cell tumors].
Wang L; Dong Y; Li Q; Li H; Sun X; Zhou X; Li X
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):118-22. PubMed ID: 25916643
[TBL] [Abstract][Full Text] [Related]
14. Malignant Brenner tumor with peritoneal metastasis.
Hayashi K; Takahashi K; Sonobe H; Ohtsuki Y; Yoshino T; Tsutsumi A; Taguchi K; Fujimori T
Acta Pathol Jpn; 1987 Jul; 37(7):1199-206. PubMed ID: 3661200
[TBL] [Abstract][Full Text] [Related]
15. Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen.
Ordóñez NG
Histopathology; 1997 Dec; 31(6):517-24. PubMed ID: 9447382
[TBL] [Abstract][Full Text] [Related]
16. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Brenner tumors and transitional cell carcinoma: recent developments.
Roth LM; Gersell DJ; Ulbright TM
Int J Gynecol Pathol; 1993 Apr; 12(2):128-33. PubMed ID: 8463036
[TBL] [Abstract][Full Text] [Related]
18. Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: a case report.
Labonté S; Têtu B; Boucher D; Larue H
Hum Pathol; 2001 Feb; 32(2):230-2. PubMed ID: 11230712
[TBL] [Abstract][Full Text] [Related]
19. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
[TBL] [Abstract][Full Text] [Related]
20. Selective expression of cytokeratin polypeptides in various epithelia of human Brenner tumor.
Lifschitz-Mercer B; Czernobilsky B; Shezen E; Dgani R; Leitner O; Geiger B
Hum Pathol; 1988 Jun; 19(6):640-50. PubMed ID: 2454213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
